584 results found
This Committee was established to provide guidance and advice on the project.
The NHMRC Corporate Plan 2021–22 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan includes updated strategic priorities and health priorities and outlines our planned key activities in 2021–22 and over the next four years. The plan also describes the operating context in which we work and our performance criteria and targets for the next four years.
The National Health and Medical Research Council (NHMRC) Corporate Plan 2022–23 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan also includes our strategic priorities and health priorities and outlines our key activities planned for 2022–23 and over the next four years. In addition, the plan describes the operating context in which we work and our performance criteria and targets for the next four years
Road map II: A strategic framework for improving the health of Aboriginal and Torres Strait Islander people through research will be used by the NHMRC’s Research Committee to identify research topics requiring priority funding.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21. An accessible version of this document is available on the Transparency Portal.
The Australian Code for the Responsible Conduct of Research, 2018 (the 2018 Code) establishes a framework for responsible research conduct that provides a foundation for high-quality research, credibility and community trust in the research endeavour.
The NHMRC Corporate Plan 2023–24 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2023–24 and over the next four years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years. The key elements of our Corporate Plan 2023–24 are summarised in the Plan on a Page.
The NHMRC Corporate Plan 2024-25 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2024–25 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.
The Report of the Independent Review of the Prohibition of Human Cloning for Reproduction Act 2002 and the research involving human embryos Act 2002 offers a review of legislation regarding the use of human clones for reproduction and the use of human embryos in research.
The Principles for the translation of ‘omics’- based tests from discovery to health care are designed to assist researchers and clinicians in translating omics-based discoveries into properly validated tests that are clinically useful*.
The Australian Code for the Responsible Conduct of Research, 2007 (the 2007 Code) guides institutions and researchers in responsible research practices and promotes research integrity. It assists institutions in developing their own employee codes of conduct and procedures for the investigation of allegations of research misconduct by providing a comprehensive framework of acceptable academic standards.
The NHMRC Corporate Plan 2025–26 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2025–26 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.
The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s). The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23. An accessible version of this document is available on the Transparency Portal.